Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors
This study is currently recruiting participants.
Study NCT00752947   Information provided by Beijing Hospital
First Received: September 15, 2008   Last Updated: March 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Community-Acquired Pneumonia
Additional conditions recognized in this trial
Pneumonia
More general conditions related to this trial
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
moxifloxacin
levofloxacin
metronidazole
Additional drug interventions recognized in this trial
Ofloxacin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
Beijing Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services